对子宫内膜癌的最小侵入性与开放性外科分期程序的比较研究:一个单一机构的经验
D Suresh Kumar1, S Navin Noushad1, Ajay Sharma1
1Tamil Nadu Government Multi Super Speciality Hospital, Chennai, Tamil Nadu India.
Indian journal of surgical oncology
|February 5, 2026
概括
对子宫内膜癌的最小侵入性手术分期提供了比开放手术更好的生存率和更少的发病率. 这种方法导致减少血液流失和更短的住院时间,证明了瘤安全性.
科学领域:
- 妇科瘤学 妇科瘤学
- 手术瘤学手术瘤学
- 最少侵入性的手术
背景情况:
- 子宫内膜癌的管理涉及手术分期,以确定范围和指导治疗.
- 传统的开放性手术分期 (laparotomy) 与显著的发病率有关.
- 最少侵入性的手术分期 (腹腔镜/机器人) 提供潜在的好处,但需要瘤学验证.
研究的目的:
- 为了比较子宫内膜癌的最小侵入性和开放性手术分期之间的瘤疗效,发病率和术后结果.
- 为了评估无病存活率,手术时间,血液损失,淋巴结产量和住院时间.
- 评估最小侵入性方法在子宫内膜癌管理中的安全性和有效性.
主要方法:
- 在2015年1月至2024年11月期间接受治疗的217名子宫内膜癌患者的回顾性分析.
- 在开放式手术分期 (n=93) 和微创手术分期 (n=124;86腹腔镜,38机器人) 之间的结果比较.
- 使用费舍尔的精确测试,学生的t测试和卡普兰-梅尔生存分析 (p≤0.05显著性) 的统计分析.
主要成果:
- 最少侵入性手术的手术时间较短 (115比136分钟,p=0.009) 并且输血明显减少 (60比140毫升,p=0.007).
- 医院住院时间较短的最少侵入性分期 (4vs6天,p=0.005),淋巴结检索没有显著差异 (p=0.09).
- 经过3年的无病生存时间在最小侵入性治疗组中更高 (95.2% vs 88.3%,p=0.003).
结论:
- 最少侵入性的手术分期是癌症安全和有效的子宫内膜癌.
- 它提供了优越的外科手术后期结果,包括减少血液损失和更短的住院时间.
- 与开放式手术分期相比,这种方法与改善无病生存率有关.
相关概念视频
Kidney Transplant II: Surgical Procedure
419
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
419
Blind Procedures
13.5K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.5K
Mouse Models of Cancer Study
6.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K
What is an Experiment?
18.8K
An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
18.8K
Cancers Originate from Somatic Mutations in a Single Cell
14.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.9K
Bioavailability Study Design: Single Versus Multiple Dose Studies
246
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
246


